GPNMB and melanoma: identified several proteins correlated with tumor tissue content by combining proteomics with histopathology and clinical outcomes, of which HEXB, PKM, and GPNMB were relatively prominent and may serve as biomarkers in progression from stage III to IV melanoma (74).